Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001225914 | SCV001398208 | uncertain significance | not provided | 2024-11-04 | criteria provided, single submitter | clinical testing | This sequence change replaces proline, which is neutral and non-polar, with serine, which is neutral and polar, at codon 372 of the RNF43 protein (p.Pro372Ser). This variant is present in population databases (rs201204271, gnomAD 0.05%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with RNF43-related conditions. ClinVar contains an entry for this variant (Variation ID: 953598). An algorithm developed to predict the effect of missense changes on protein structure and function outputs the following: PolyPhen-2: "Benign". The serine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Institute for Clinical Genetics, |
RCV001225914 | SCV002011589 | uncertain significance | not provided | 2021-11-03 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV002268457 | SCV002551094 | uncertain significance | not specified | 2025-03-04 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001225914 | SCV005900910 | uncertain significance | not provided | 2024-09-23 | criteria provided, single submitter | clinical testing | In silico analysis indicates that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 31046843) |
Zotz- |
RCV003389068 | SCV004101133 | uncertain significance | Sessile serrated polyposis cancer syndrome | 2023-11-02 | no assertion criteria provided | clinical testing |